Related references
Note: Only part of the references are listed.Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
Vipul Kumar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
Anwarul Hasan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets
Saurabh K. Sinha et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor
Ganesh Kumar Veeramachaneni et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Molecular docking, simulation and MM-PBSA studies ofnigella sativacompounds: a computational quest to identify potential natural antiviral for COVID-19 treatment
Sajjad Ahmad et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria
Imane Abdelli et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations
Alireza Paniri et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent
Abdul Basit et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
Ammar D. Elmezayen et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Identification of potential natural inhibitors of SARS-CoV2 main protease by molecular docking and simulation studies
Sanjay Gupta et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Antiviral effects of probiotic metabolites on COVID-19
Firoz Anwar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Cross-species transmission of the newly identified coronavirus 2019-nCoV
Wei Ji et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future
Jin-Yan Li et al.
MICROBES AND INFECTION (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak
Matteo Chinazzi et al.
SCIENCE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade
B. Coutard et al.
ANTIVIRAL RESEARCH (2020)
Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
Junwen Luan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase
Jrhau Lung et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein
Mushtaq Hussain et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
In Silico Discovery of Candidate Drugs against Covid-19
Claudia Cava et al.
VIRUSES-BASEL (2020)
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing as the of SARS-CoV-2
Ye Qiu et al.
MICROBES AND INFECTION (2020)
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
Cynthia Liu et al.
ACS CENTRAL SCIENCE (2020)
Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2)
Noor Rahman et al.
MOLECULES (2020)
Highly Conserved Homotrimer Cavity Formed by the SARS-CoV-2 Spike Glycoprotein: A Novel Binding Site
Umesh Kalathiya et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The proximal origin of SARS-CoV-2
Kristian G. Andersen et al.
NATURE MEDICINE (2020)
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
Waradon Sungnak et al.
NATURE MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
Muhammad Adnan Shereen et al.
JOURNAL OF ADVANCED RESEARCH (2020)
Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human
Sabyasachi Senapati et al.
JOURNAL OF GENETICS (2020)
Candidate drugs against SARS-CoV-2 and COVID-19
Dwight L. McKee et al.
PHARMACOLOGICAL RESEARCH (2020)
Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and interactions
Yingjie Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
Ritesh Gupta et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Analysis of RNA sequences of 3636 SARS-CoV-2 collected from 55 countries reveals selective sweep of one virus type
Nidhan K. Biswas et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India
Manohar Lal Choudhary et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
Mapping the genomic landscape & diversity of COVID-19 based on > 3950 clinical isolates of SARS-CoV-2: Likely origin & transmission dynamics of isolates sequenced in India
Hina Singh et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
Drug targets for corona virus: A systematic review
Manisha Prajapat et al.
INDIAN JOURNAL OF PHARMACOLOGY (2020)
Repurposing host-based therapeutics to control coronavirus and influenza virus
Cui-Cui Li et al.
DRUG DISCOVERY TODAY (2019)
Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2
Lennart Michel Reinke et al.
PLOS ONE (2017)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Circulating ACE2 activity correlates with cardiovascular disease development
Katalin Uri et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis
Chun-Jung Ko et al.
CANCER RESEARCH (2015)
A Single Point Mutation Creating a Furin Cleavage Site in the Spike Protein Renders Porcine Epidemic Diarrhea Coronavirus Trypsin Independent for Cell Entry and Fusion
Wentao Li et al.
JOURNAL OF VIROLOGY (2015)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Vineet D. Menachery et al.
NATURE MEDICINE (2015)
Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond
Guangwen Lu et al.
TRENDS IN MICROBIOLOGY (2015)
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Jean Kaoru Millet et al.
VIRUS RESEARCH (2015)
Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
Raphael N. Vuille-dit-Bille et al.
AMINO ACIDS (2015)
TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells
Pawel Zmora et al.
PLOS ONE (2015)
TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein
Adeline Heurich et al.
JOURNAL OF VIROLOGY (2014)
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure
Katalin Uri et al.
PLOS ONE (2014)
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
Jean Kaoru Millet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Receptor recognition and cross-species infections of SARS coronavirus
Fang Li
ANTIVIRAL RESEARCH (2013)
Identification of the first synthetic inhibitors of the type II transmembrane serine protease IMPRSS2 suitable for inhibition of influenza virus activation
Daniela Meyer et al.
BIOCHEMICAL JOURNAL (2013)
Interspecies transmission and emergence of novel viruses: lessons from bats and birds
Jasper Fuk-Woo Chan et al.
TRENDS IN MICROBIOLOGY (2013)
Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts
Stephanie Bertram et al.
PLOS ONE (2012)
Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence
Taylor Heald-Sargent et al.
VIRUSES-BASEL (2012)
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Sandrine Belouzard et al.
VIRUSES-BASEL (2012)
A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry
Ana Shulla et al.
JOURNAL OF VIROLOGY (2011)
Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease
Stephanie Bertram et al.
JOURNAL OF VIROLOGY (2011)
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2011)
Novel insights into proteolytic cleavage of influenza virus hemagglutinin
Stephanie Bertram et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function
Carlos M. Ferrario et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Proteolytic Activation of the Spike Protein at a Novel RRRR/S Motif Is Implicated in Furin-Dependent Entry, Syncytium Formation, and Infectivity of Coronavirus Infectious Bronchitis Virus in Cultured Cells
Yoshiyuki Yamada et al.
JOURNAL OF VIROLOGY (2009)
A protein complex in the brush-border membrane explains a Hartnup disorder allele
Sonja Kowalczuk et al.
FASEB JOURNAL (2008)
Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry
Kathryn E. Follis et al.
VIROLOGY (2006)
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection
S Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2
Y Zhang et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2005)
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
CM Ferrario et al.
CIRCULATION (2005)
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder
R Kleta et al.
NATURE GENETICS (2004)
Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys
H Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
